臨床試験を検索：エンシフェントリン (以前の RPL554) 3.0 mg 1 日 2 回とプラセボ、さらにチオトロピウム
合計4件
-
Verona Pharma plcIqvia Pty Ltd; LGC Limited完了
-
Mothaffar Rimawi終了しました
このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。
スポンサーと協力者
- Medtronic Atrial Fibrillation Solutions
- The Västerbotten county council
- Artromedical Konrad Malinowski Clinic
- Diógenes Foundation
- Campus Venlo
- Immunwork, Inc.
- Annie E. Casey Foundation
- Jonathan Liew Wee Kent
- Swiss School of Public Health (SSPH+)
- PharmaLogic Development, Inc.
- Associazione Diamo Peso al Benessere
- Life Sciences Development Fund
- Max Planck Institute for Metabolism Research
- Ospedale Di Venere, ASL BA, Bari Italy
- Renyi Qin
- Maternal Breastfeeding Incentive Center (CIAMA)
- Visionaturolab INC.
- Freedom For All Diagnostics
- VIMRx Pharmaceuticals
- Phoenix Children's Hospital Center for Cancer & Blood Disorders
- 全リストを表示
CROs by country
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Italy
- Contract Research Organizations in Japan
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Poland
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Suriname
- Contract Research Organizations in Türkiye
- Contract Research Organizations in Vietnam
- Contract Research Organizations in Zambia
- CRO list by country